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Background: The use of liquid herbal preparations in the treatment and management of human diseases has long 
been practiced before the advent of chemotherapy and is a fundamental component of the African traditional 
healthcare system.  
Objectives: The objective of this study is to analyze the bacteriological profile and in vitro antibacterial activities of 
selected indigenous liquid herbal products sold in Abia State, Nigeria. METHODS: A total of 315 bacterial strains were 
isolated from 150 therapeutic liquid herbal preparations (LHPs) sold in different parts of Abia State. Pathogenic 
bacteria were isolated from these products; the isolates were evaluated for total aerobic plate count, Gram’s reaction, 
biochemical reaction. Antibacterial activity was assessed using minimum inhibitory concentration (MIC), minimum 
bactericidal concentration (MBC) and inhibitory zone diameter (IZD).The MBC, MIC and invitro antibacterial activities 
of LHPs were carried out against 3 test clinical bacterial isolates; Staphylococcus aureus, Escherichia coli and 
Pseudomonas aeruginosa, using agar well diffusion methods. 
Results: The number of isolates obtained in this study were; 100 (31.4%), 84 (26.7%) 131 (41.6%) from Umuahia, 
Ohafia and Aba respectively. The genera isolated included Salmonella, Bacillus, Escherichia, Klebsiella, Proteus, 
Staphylococcus, Streptococcus, Citrobacter and Pseudomonas. Out of 150 LHPs processed, 20 showed no bacterial 
growth. Different concentrations of these LHPs were evaluated for their antibacterial activities. MIC for LHPs with 
antibacterial activities range from 6.25-100%. MBC ranged from 12.5-100%, while IZD had range of 6-20mm.  
Conclusion: The study revealed that some tested liquid herbal preparations were grossly contaminated with bacteria 
while some had antibacterial activities. 
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1. Introduction 
Herbal medicines may be associated with a broad 
variety of microbial load and exert an important impact 
on overall quality of herbal products and preparations 
(Onyambu et al, 2013). Traditional herbalists in Nigeria 
use various herbal preparations to treat various types 
of ailments, including diarrhea, urinary tract infection, 
typhoid fever and skin diseases (Sofowora, 1993). Most 
of the herbal preparations are used in different forms 
and normally carry a large number of various kinds of 
microbial contaminants originating from soil and are 
normally adhered to leaves, stem, flowers, seeds and 
root of the herbs (Adeleye et al, 2005). Erich et al. 
(2001) studied 138 medicinal herbal drugs and 
reported association of several microbial pathogens 
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including enterohaemorrhagic E. coli, Staphylococcus 
aureus, Candida albicans and Campylobacter.  
Higher humidity facilitates enhancement of microbial 
population during storage of herbal drugs and causes 
severe loss of medicinally important chemical 
components which are utilized as nutrient components 
by harbored heterogeneous microbial flora. Their count 
varies with storage period and climatic conditions even 
after best storing packages and conditions. Prasad et al. 
(2002) made a quantitative enumeration of microbial 
flora of certain herbal drugs and found that all the drug 
samples were highly contaminated. Herbal medicinal 
preparations, if unpreserved, readily become 
contaminated with adventitious microorganisms 
leading to spoilage (Tella, 1978). On one hand, such 
grossly contaminated herbal medicinal products may 
serve as potential sources of transmission of pathogenic 
organisms from products to consumers (Okunade A.O., 
2001, Onyambu et al, 2013). In Abia State, however, 
even though, there is proliferation of herbal products in 
the market, not much has been done in this field. The 
use of contaminated herbal medicinal drugs could 
create problems for the patient who sometimes could 
develop acute diarrhea symptoms that could be life 
threatening. 
The objective of this study is to evaluate the bacterial 
diversity of pathogens that could contaminate the liquid 
herbal medicinal preparations and also to ascertain if 
some of the herbs have in vitro antimicrobial activity 
against some clinical isolates. 
2. Methods 
2.1 Study Area and Sample Collection 
A total of 150 samples were purchased from different 
places in Abia State (50 each from Umuahia, Ohafia and 
Aba). All the samples collected from the sites were 
analyzed in the Postgraduate Microbiology Laboratory, 
College of Natural Sciences, Michael Okpara University 
of Agriculture, Umudike, Abia State. These herbal 
preparations which had various therapeutic claims 
were purchased from different vendors to get as many 
different brands as possible. The samples were within 
their shelf lives, were kept at room temperature and 
were analyzed within two weeks of collection. The 
sealed bottles of herbal preparations were cleaned with 
70% ethanol before opening to prevent contamination. 
2.2 Materials 
The herbal preparations used for this study were all in 
liquid formulations with different plant parts (i.e. bark, 
roots, wood etc) which are either active ingredients or 
preservatives. All herbal preparations were given codes 
- LHP and numbers for specificity.  
2.3 Microbiological tests 
2.3.1 Total aerobic plate count and identification of 
isolates 
Surface viable count of some LHPs was carried out by 
the method of Miles and Misra (1938). A ten-fold serial 
dilution of the LHPs was made. A series of 9 McCartney 
bottles containing 9mL of sterile peptone water each 
were placed on a sterilized bench. With a sterile 
delivery pipette, 1mL of the collected sample was 
transferred into the first bottle of diluents (10-1), with 
another fresh sterile 1mL pipette; 1mL from the first 
dilution was transferred into the second bottle of 
diluents (10-2) dilution. This was done until 10-10 
dilution was achieved. 0.02ml of each LHP was allowed 
to fall from a height of 2.5cm on to plate count agar and 
spread over an area of 1.5-2.0cm diameter. Counts were 
made in the drop areas showing the largest number of 
colonies without confluence (up to 20 or more). The 
plates were incubated for a maximum of 48hrs at 370C. 
Finally the counting of the bacterial colonies was done 
using a Digital colony counter (Harrigan et al, 1993). 
The Gram staining technique was used as the staining 
reaction to identify the different bacteria species in each 
liquid herbal preparation by their Gram reaction (Gram 
positive or Gram negative) and their morphology. All 
Gram stained smears of different colonies on different 
cultures were examined using oil immersion objectives 
(x100) of a compound microscope to check the staining 
reaction and morphology of the bacteria species and 
then with the oil immersion objective. A series of 
biochemical methods e.g., coagulase test, oxidase test, 
indole test, citrate test, sulphate reduction test, catalase 
test, methyl red test, triple sugar iron test, motility test, 
Voges-Proskauer test was used in identifying and 
classifying bacterial isolates (Baron et al, 1990, Bachoon 
et al,2008). 
2.3.2 Tube dilution test for minimum inhibitory 
concentration (MIC) 
Liquid herbal preparations with antibacterial activity 
were prepared in 1:2, 1:4, and 1:8 dilutions or by 
making serial twofold dilutions (i.e. 3.125 %, 6.25 %, 
12.5 %, 25 %, 50 % and 100%) in sterile stoppered test 
tubes. To each series doubling dilutions one drop of 
clinical bacterial isolates (Staphylococcus aureus, 
Escherichia coli and Pseudomonas aeruginosa) from an 
overnight nutrient broth culture was added aseptically 
to each tube including tubes of uninoculated LHPs to act 
as controls. These were incubated for 18-24h at 370C 
and examined for turbidity due to bacterial growth. The 
tube with the least dilution of LHP showing no visible 
turbidity was read as the one containing the minimum 
inhibitory concentration (MIC) of the LHP for the test 
bacterial isolate (CLSI, 2008). 
2.3.3 Tube dilution test for minimum bactericidal 
concentration (MBC) 
The tube dilution test was used to measure the 
minimum bactericidal concentration (MBC) of potent 
LHPs. Before incubating each series of inoculated tubes 
from the tube dilution test for minimum inhibitory 
concentration, 0.02ml, from the tube without any 
dilution of LHPs was spread uniformly over a plate of 
nutrient agar. After incubation of the tubes, a loopful 
from each tube not showing growth was spread over 
nutrient agar plates. The plate cultures were incubated 
for 24hours. The tube culture containing the least 
dilution that yields no growth in the plate subculture 
was read as the MBC of the LHP for each test bacteria 
isolate. The plate sub-cultures yielding growth was 
compared with that cultured from the control tube 
cultures before incubation to determine whether there 
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was some bactericidal action on only bacteriostasis 
(CLSI, 2008). 
2.3.4 Inhibition zone diameter measurement (Agar 
well diffusion assay)  
Three clinical bacterial isolates (Staphylococcus aureus, 
Escherichia coli and Pseudomonas aeruginosa) were 
obtained from the Microbiology Laboratory, Federal 
Medical Centre, Umuahia, Abia State, Nigeria; for the 
antimicrobial screening of the liquid herbal products. 
Four morphologically similar colonies of these clinical 
bacterial isolates was collected with a sterile loop and 
transferred for growth in peptone broth and incubated 
with shaking at 35-37°C until the visible turbidity is 
equal to or greater than the 0.5 McFarland standard.   
Adequate light to visually compare the inoculum tube 
and the 0.5 McFarland standard against a card with a 
white background and contrasting black line (Hugo and 
Russel, 2004, CLSI, 2012). Intermediate dilutions of 
LHPs were prepared by making successive 1:2, 1:4, and 
1:8 dilutions or by making serial twofold dilutions. One 
part of these dilutions was added to nine parts of 
molten Mueller–Hinton agar (MHA) (Oxoid, UK) and 
allowed to equilibrate in a water bath to 45 to 50°C. the 
molten Mueller–Hinton agar and dilutions of  LHPs was 
mixed thoroughly and poured aseptically into Petri 
dishes on a level surface to result in an agar depth of 3 
to 4 mm. Mueller–Hinton agar plates without LHPs was 
used as controls. Six wells (6mm) were made in the agar 
with aid of cork borer No. 4. The wells were sealed at 
the bottom with molten sterilized agar, Aliquot of each 
well-mixed adjusted and diluted bacterial suspensions 
(107 CFU/mL) was placed into the corresponding wells 
with standardized pipettes. A growth-control plate (no 
LHPs) was inoculated and a second growth control plate 
to ensure there was no contamination or significant 
antimicrobial carryover during the inoculation. 
Antibiotic disc (Ciprofloxacin- 5μg) used as control was 
placed on the agar aseptically.  
The plates were then incubated at 37°C for 24 hours. 
The zone diameters of inhibition produced by each 
dilutions of the liquid herbal product and that of the 
antibiotic disc was measured and recorded in 
millimetres (CLSI, 2013). 
2.3.5 Antibiotics susceptibility test 
Antimicrobial susceptibility testing of the isolated 
organisms was performed by the disk diffusion 
technique following the method recommended by the 
Clinical Laboratory Standards Institute (CLSI, 2013). All 
the microbial strains were sub-cultured on a freshly 
prepared nutrient agar plate 24hour prior to 
antimicrobial test. Inocula were prepared by 
transferring several single colonies of bacteria to a 
sterile broth. A sterile, non-toxic cotton swab was 
dipped into the standardized Inocula and used to 
spread the entire surface of Mueller Hinton agar plates 
(Bauer et al, 1996, CLSI, 2013). Antibiotics discs were 
placed aseptically on the surface of the agar plates using 
sterilized forceps and thereafter incubated at 370C for 
24hours. 
Antibiotic discs used to determine the antibacterial 
susceptibility include; Amoxicillin/Clavulanate (AMC) 
30μg, Ofloxacin (OFL) 5μg,Gentamicin (GEN) 10μg, 
Peflacin (PEF) 10 μg, Ciproflox (CIP) 30μg, Streptomycin 
(S) 30 μg, Ceftriaxone (CRO) 30μg,  Amoxil (AML) 20μg, 
Cefuroxime (CXM) 30 μg and Cefotaxime (CTX) 30 μg. 
Erythromycin (ERY) 5μg, Cloxacillin (CXC) 5μg and 
Chloramphenicol (CH) 30μg. All disks were obtained 
from Oxoid Ltd. (Basingstoke, UK) 
The diameters of the zones of inhibition were read after 
24hours of incubation of 370C. Data for resistant were 
reported. 
2.4 Multiple antibiotic resistances calculation   
Calculation of Multiple Antibiotic Resistance (MAR) 
index was done by the method of Riaz et al, 2011, using 
the formula: 
MAR = a/(b.c) 
Where: 
a = the aggregate resistance of antibiotics to all 
isolates,  
b = the total number of antibiotics  
c = the number of isolates from the specimen site.   
3. Results  
Table 1 shows the incidence and distribution of 
bacterial contaminants isolated from all sampled liquid 
herbal preparations (LHPs). A total of 315 bacterial 
strains were isolated, with 100 strains isolated from 50 
LHPs in Umuahia, 84 strains isolated from 50 LHPs in 
Ohafia and 131 strains isolated from 50 LHPs collected 
in Aba, all in Abia State. Bacteria genera isolated 
cultured and identified include Salmonella, Bacillus, 
Escherichia, Klebsiella, Proteus, Staphylococcus, 
Streptococcus, Citrobacter and Pseudomonas all 
occurring in varying viable counts per milliliter. The 
incidence of species of Enterobacteriaceae was 
significant in most LHPs collected. Also significant is the 
high occurrence of spore forming Bacillus spp., in 49 
(16%) liquid herbal preparations, which indicates the 
unhygienic preparation and handling of these products.  
Table 2 presents the minimum inhibitory concentration 
(MIC), minimum bactericidal concentration (MBC)  and 
antibacterial activities measured in inhibitory zone 
diameter (in millimeters) of some liquid herbal 
preparations (LHPs) against 3 test clinical bacteria 
isolates, namely Staphylococcus aureus, Escherichia coli 
and Pseudomonas aeruginosa. 
MIC for LHPs with antibacterial activities range from 
6.25-50%, for S. aureus, 6.25-100%, for E. coli and 6.25-
100% for P. aeruginosa. MBC of LHPs against test 
isolates range from 12.5-100% for S. aureus, E. coli, P. 
aeruginosa. Inhibitory zone diameters (IZD) of test 
isolates against LHPs range from 6-19mm for S. aureus, 
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Table 1: Bacteria Contaminants of Some Liquid Herbal Preparations in Abia State 










Salmonella spp 5(5) 5(6) 6(5) 16(5) 
Bacillus spp. 13(13) 15(18) 21(16) 49(16) 
Escherichia coli 13(13) 11(13) 23(18) 47(15) 
Klebsiella pneumoniae 0(0) 19(23) 10(8) 29(9) 
Proteus vulgaris 11(11) 0(0) 0(0) 11(4) 
Staphylococcus aureus 14(14) 11(13) 16(12) 41(13) 
Streptococcus spp 0(0) 12(14) 13(10) 25(8) 
Citrobacter freundii 9(9) 0(0) 10(8) 19(6) 
Pseudomonas aeruginosa 22(22) 11(13) 21(16) 54(17) 
Coagulase Negative Staphylococci 13(13) 0(0) 11(8) 24(8) 
 
Table 2: Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC) and Antibacterial 
Activities (Inhibitory Zone Diameter) of Some Liquid Herbal Preparations on Test Bacteria Isolates 
 Staphylococcus aureus  Escherichia coli  Pseudomonas aeruginosa 



















11 12.5 25 13  50 100 6  100 100 6 
18 12.5 25 15  50 100 10  100 100 8 
20 6.25 12.5 17  100 100 7  12.5 25 16 
24 12.5 25 11  6.25 12.5 20  12.5 25 14 
25 25 50 9  12.5 25 10  25 50 15 
27 6.25 12.5 19  100 100 6  25 50 12 
30 6.25 12.5 14  25 50 15  25 50 13 
42 25 50 9  25 50 14  12.5 25 20 
58 12.5 25 16  12.5 25 20  25 50 11 
59 25 50 13  50 100 16  50 100 8 
62 25 50 16  100 100 7  50 100 7 
73 25 50 10  50 100 8  50 100 10 
81 25 50 14  25 50 10  25 50 9 
86 50 100 6  12.5 25 14  25 50 14 
91 50 100 9  25 50 13  12.5 25 15 
103 25 50 11  50 100 9  12.5 25 15 
112 25 50 13  100 100 9  12.5 25 11 
125 25 50 10  50 100 8  6.25 12.5 16 
136 12.5 25 18  25 50 15  6.25 12.5 18 
146 6.25 12.5 19  12.5 25 13  6.25 12.5 14 
 
The antibiotic resistance profiles of bacteria isolates 
from liquid herbal preparations (LHPs) are given in 
Table 3. The resistance pattern of LHP isolates varied 
among antibiotics used and shows 47 (17.9%) isolates 
were resistant to Amoxycillin-Clavulanate, while 5 
(1.9%) isolates were resistant to Ciprofloxacin. Table 4 
shows the multiple antibiotic resistance (MAR) index of 
the isolates. The MAR ranged from 0.24 – 0.34.  
 
  
Table 3: Antibiotic Resistance Profile Bacteria Isolated From Some Liquid Herbal Preparations  
 Number and (%) Resistant 
Bacterial Isolates AMC OFL GEN PEF CIP S CTX CXM CRO ERY CXC AML CH 
Salmonella spp. (n=16) 2(12.5) 2(12.5) 2(12.5) 1(6.3) 4(25) 2(12.5) 1(6.3) 11(68.8) 5(31.3) NT NT 8(50) NT 
Escherichia coli (n=47) 25(52.5) 5(10.5) 10(20.1) 3(6.3) 10(20.1) 15(31.5) 13(27.3) 23(48.3 4(8,4) NT NT 32(67.2) NT 
Proteus vulgaris (n=11) 4(36.4) 2(18.2) 1(9.1) 4(36.4) 4(36.4) 2(18.2) 6(54.6) 6(54.6) 1(9.1) NT NT 7(63.7) NT 
Citrobacter freundii (n=19) 6(31,8) 4(21.2) 7(37.1) 7(37.1) 5(26.5) 5(26.5) 5(26.5) 8(42.4) 2(10.6) NT NT 8(42.4) NT 
P. aeruginosa (n=54) 54(100) 6(11.4) 7(13.3) 3(5.7) 1(1.9) 4(7.6) 54(100) 54(100) 3(5.7) NT NT 54(100) NT 
Klebsiella pneumonia (n=29) 14(49) 5(17.5) 4(14.5) 6(21) 3(10.5) 4(14.5) 4(14.5) 15(52.5) 1(3.5) NT NT 16(56) NT 
Staph. aureus (n=49) 27(54) 12(24) 5(10) 5(10) 7(14) 10(20) 20(40) 29(58) 20(40) 4(8) 2(4) 40(80) 32(64) 
Strep. spp. (n=25) 10(40) 12(48) 10(40) 5(20) 5(20) 8(32) 10(40) 5(20) 11(44) 4(16) 4(16) 10(40) 15(60) 
Coagulase Negative 
Staphylococci (n=24) 
12(50.4) 15(63) 5(21) 6(25.2) 7(29.4) 10(42) 10(42) 1(4.2) 10(42) 2(16.8) 2(16.8) 20(84) 15(63) 
AMC= Amoxycillin-Clavulanate 30μg, OFL= Ofloxacin 5μg, GEN= Gentamicin 10μg, PEF=Peflacin 10 μg, CIP= Ciproflox 10μg, S=Streptomycin 30 μg, CTX=Cefotaxime 30 μg, CXM =Cefuroxime 30μg, 
CRO= Ceftriaxone 30μg, ERY= Erythromycin 5μg,   CXC= Cloxacillin 5μg, AML= Amoxil 20μg, CH= Chloramphenicol 30μg, NT = NOT TESTED 
 
Table 4: Multiple antibiotic resistances (MAR) of isolates 
Isolate MAR 
Salmonella spp. 0.24 
Escherichia coli 0.30 
Proteus vulgaris 0.34 
Citrobacter freundii 0.30 
Pseudomonas aeruginosa 0.44 
Klebsiella pneumonia 0.25 
Staphylococcus aureus 0.33 
Streptococcus spp. 0.34 
Coagulase Negative Staphylococci 0.34 
 
 4.0 Discussion 
In developing nations, low income individuals use 
herbal remedies for the treatment of common infections 
(Rojas et al, 2006). Most of these herbal preparations 
are widely distributed, hawked by vendors and 
consumed orally in most localities in Nigeria. In this 
study 150 liquid herbal preparations (LHPs) were 
collected from different representative towns in Abia 
State, Nigeria namely Umuahia (Abia Central), Ohafia 
(Abia North) and Aba (Abia South). These LHPs were 
hawked in transparent plastic containers by mostly 
female vendors on daily basis for medicinal purposes 
and from rate of sales; these herbal products have wide 
acceptance and demand. The level of bacterial 
contaminants of LHPs is quite evident in this study as 
130 (86.7%) LHPs were found to harbor different 
species of bacteria. This agrees with the studies by 
Ujam, et al, 2013, Esimone et al, 2007 and Ampofo 2012. 
Agbo et al, 2012 identified different bacteria species in 
LHP consumed in Nigeria i.e. Bacillus spp (23.81%), 
Proteus vulgaris (14.280%), Klebsiella spp. (9.52%), 
staphylococcus aureus (9.52%), Escherichia coli (4.76%) 
and Pseudomonas, aeruginosa (4.76%). The proportion 
of Klebsiella spp from this Agbo et al, 2012 agrees with 
ours, while isolates were disproportionate.. 
The frequency of bacterial species agrees with results of 
previous studies on microbial contamination of 
traditional herbal medicinal products (Nakajima et al, 
2005, Baba-Moussa et al, 2013). The high rates of 
bacterial contamination which have been reported 
severally (Khanyile et al, 2009, Kulkarni et al, 1999), 
maybe due to lack of stringent regulations of LHPs by 
regulatory agencies. Ampofo et al, 2012 in a similar 
study of microbial quality of 31 herbal preparations 
indicates 39% contamination with diverse 
heterotrophic bacteria, only 19 herbal samples in the 
study by Ampofo et al, 2012  were found to be 
microbiologically safe to be consumed. 
Salmonella spp. also occurred in 5% of all assessed 
LHPs from Aba and is of health concern having been 
reported to be mostly associated with juvenile 
gastroenteritis. This is less when compared to findings 
of Ampofu et al, 2012, in which Salmonella spp., 
occurred in 9.7% of herbal medical products assayed in 
Ghana. 
The high incidence of Bacillus spp., in 16% of LHPs 
suggest contamination from soil, air and dust where it’s 
highly distributed. Similar studies by Oleghe et al, 2011 
reported 39% Bacillus spp., occurrence in herbal 
preparation sold in Nigeria. 
E. coli was isolated in 15% of  LHPs, which is less when 
compared to 20% occurrence reported by Ujam et al, 
2013 of E. coli isolated from herbal medicinal products 
in south east Nigeria. This also constitutes health hazard 
as reports have shown that E. coli is a major 
diarrhogenic pathogen (Gregory, 2005, Forest, 2004). 
Other Gram negative bacteria isolated in different 
counts from LHPs include K. pneumonia, P. vulgaris, 
Citrobacter freundii and Pseudomonas aeruginosa have 
also been reported (Abba et al, 2009, Kolajo, 2000). 
Klebsiella pneumoniae occurred in 9% of LHPs and this 
agree with the report of Adenike et al; 2007 and has 
been implicated in bronchitis (Nordmann et al, 2009). 
Proteus vulgaris was isolated from 4% of LHPs which is 
less than 8% reported by Ujam et al, 2013. Proteus 
serovars have been reported as well to be associated 
with diarrhea diseases (Jiva et al, 1988). 
Staphylococcus aureus was isolated from 13% of LHPs 
which is more than the 9% occurrence reported by 
Esimone et al, 2007.Contamination with Staphylococcus 
aureus is indicative of improper handling during 
processing, distribution or storage of LHPs Abba et al, 
2009). The occurrence of Streptococcus spp in 8% of 
LHPs corresponds slightly with the findings of Ujam et 
al, 2013 and has health implications. The presence of 
bacterial contaminants in non-sterile medicinal 
preparations can reduce and even inactivate the 
therapeutic activity of the products and has the 
potential to adversely affect individuals taking it 
(Nakajima et al, 2005, Okunlola et al, 2007).  
This study shows that 20(13%) LHPs were found to 
exhibit in-vitro antibacterial activity. Studies by 
Esimone et al, 2007 and Ujam et al, 2013, reports 58% 
and 60% antibacterial potency of herbal products 
respectively.  
Analysis of the multiple antibiotic resistance index of 
the isolates showed that seven (7) out of the ten (10) 
genera of bacteria had MAR values in the risk zone. This 
agrees with the findings of Riaz et al, 2011 who 
reported that E. coli and Klebsiella isolates obtained 
from their study equally showed MAR index in the risk 
zone and they were resistance to some antibiotics of 
cephalosporin group. 
In evaluating the MIC and MBC potent LHPs were tested 
against 3 clinical isolates; Staphylococcus aureus, 
Escherichia coli and Pseudomonas aeruginosa. MIC for 
LHPs with antibacterial activities range from 6.25-50%, 
for S. aureus, 6.25-100%, for E. coli and 6.25-100% for P. 
aeruginosa. This corresponds with the findings of 
Shermin et al, 2014 and Abba et al, 2009. Mean MBC of 
LHPs against test isolates range from 12.5-100% for S. 
aureus, E. coli, P. aeruginosa. Mean inhibitory zone 
diameters (IZD) of test isolates against LHPs range from 
6-19mm for S. aureus, 6-20mm for E. coli and P. 
aeruginosa. This agrees favorably with the findings of 
Sharmin et al, 2014 and Ujam et al, 2013.The proportion 
of antibiotic resistant bacterial isolates from LHPs 
differ, with findings of Esimone et al, 2007 as it 
indicated high values for augmentin (amoxicillin-
clavuanate-80%), cloxacillin (88.3%), chloramphenicol 
(66%), erythromycin (34.1%), cefotaxime (79.5%) 
cefuroxime (100%) and ciprofloxacin (147%). Also the 
proportion of resistance isolated in our studies i.e 
streptomycin (21.9%), gentamycin (15.3%), ofloxacin 
(23%) and peflacin (14.6%) were higher and differ from 
the findings of Esimone et al, 2007. 
Consequently the observed inhibitory effects of the 
LHPs in the present study on the tested bacterial 
isolates are a justification for the need to explore the 
various traditional modes of diseases treatments in 
order to determine their various antimicrobial 
efficacies.  
There is high level of bacterial contamination in liquid 
herbal preparations in Abia State. The contaminations 
of liquid herbal preparations were attributable to both 
individuals and system-centered risk factors. This 
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confirms observations of earlier studies on the use and 
consumption of herbal remedies in the treatment of 
diseases (Abba et al, 2009, Adeleye et al, 2005). Despite 
the increasing use of herbal preparations in most 
countries, there still remain numerous issues about the 
microbial quality and safety of these phytotherapeutics. 
The presence of diverse range of bacteria strains in 
LHPs poses serious public health implication as it has 
been known to be implicated in serious infection 
induced disease which could assume high level of 
morbidity and mortality (Hugo and Russell, 2004).Thus, 
the urgent need for the appropriate regulation and 
standardization of herbal preparations. Therefore, there 
is an urgent need to have specific programs, policies 
and regulations addressing herbal medicine safety 
which are specifically focused on prevention of 
microbial contamination, so as to prevent the possibility 
of these pathogens to be involved in deadly invasive 
infections.  
5.0 Conclusion  
The liquid herbals drugs were collected from 3 major 
locations in the State namely, Umuahia, Ohafia and Aba 
and showed the most frequently isolated bacteria as 
Pseudomonas aeruginosa 22%, Klebsiella pneumonia 
23%, and E. coli 18% respectively. The MIC and MBC of 
some selected herbal medicinal preparations against 
Pseudomonas aeruginosa, E. coli and S. aureus showed 
very encouraging results. 
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